
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.65 | 0.65 | 0.00 |
Shares | 98.57 | 98.57 | 0.00 |
Convertible | 0.04 | 0.04 | 0.00 |
Preferred | 0.24 | 0.24 | 0.00 |
Other | 0.50 | 0.50 | 0.00 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 18.56 | 18.77 |
Price to Book | 4.37 | 4.27 |
Price to Sales | 1.79 | 2.29 |
Price to Cash Flow | 15.19 | 15.61 |
Dividend Yield | 1.30 | 1.18 |
5 Years Earnings Growth | 11.06 | 11.14 |
Number of long holdings: 108
Number of short holdings: 0
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 9.78 | 760.08 | -0.38% | |
UnitedHealth | US91324P1021 | 5.36 | 266.04 | +1.90% | |
AstraZeneca | GB0009895292 | 4.07 | 11,370.0 | -1.11% | |
Boston Scientific | US1011371077 | 3.20 | 106.76 | +0.27% | |
Sanofi | FR0000120578 | 3.18 | 81.44 | -4.77% | |
Abbott Labs | US0028241000 | 3.06 | 128.55 | +0.42% | |
Vertex | US92532F1003 | 2.93 | 469.16 | +0.16% | |
AbbVie | US00287Y1091 | 2.57 | 189.31 | -1.00% | |
Amgen | US0311621009 | 2.51 | 301.37 | -0.72% | |
Novartis ADR | US66987V1098 | 2.44 | 116.63 | -0.50% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Janus Research D | 18.82B | 9.01 | 28.47 | 14.89 | ||
Janus Balanced I | 12.23B | 7.81 | 13.13 | 9.42 | ||
Janus Enterprise I | 9.67B | 3.19 | 13.83 | 11.94 | ||
Janus Henderson Balanced Portfolio | 8.81B | 7.75 | 12.89 | 9.14 | ||
Janus Enterprise N | 6.74B | 3.24 | 13.94 | 12.04 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review